Citadel Advisors’s LianBio American Depositary Shares LIAN Stock Holding History

Citadel Advisors’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-507,806	Closed	-$757K	–	15533
2023 Q3	$757K	Buy	507,806 +381,749	+303%	+$727K	﹤0.01%	7175
2023 Q2	$287K	Buy	126,057 +14,295	+13%	+$32.9K	﹤0.01%	9138
2023 Q1	$218K	Sell	111,762 -30,431	-21%	-$63K	﹤0.01%	10027
2022 Q4	$233K	Sell	142,193 -697,976	-83%	-$1.09M	﹤0.01%	9824
2022 Q3	$1.67M	Buy	840,169 +2,996	+0.4%	+$7.17K	﹤0.01%	5934
2022 Q2	$1.81M	Buy	837,173 +128,867	+18%	+$438K	﹤0.01%	5743
2022 Q1	$2.63M	Buy	+708,306	New	+$2.93M	﹤0.01%	5476

Other funds holding LIAN

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Citadel Advisors's LIAN Position: Q4 2023 in Review

Citadel Advisors sold out of LianBio American Depositary Shares (LIAN) in Q4 2023, closing a stake of 507,806 shares — an estimated $757K sold.

Citadel Advisors first reported a position in LIAN in Q1 2022 and held it in 7 quarters. The position peaked at $2.63M in Q1 2022. 29 funds tracked by Wall St. Rank hold LIAN as of Q4 2023.

Citadel Advisors reported no remaining LianBio American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Citadel Advisors sold 507,806 LianBio American Depositary Shares shares in Q4 2023, an estimated $757K.
Citadel Advisors first reported a position in LianBio American Depositary Shares in Q1 2022 and held it in 7 quarters.
Citadel Advisors's LianBio American Depositary Shares position peaked at $2.63M in Q1 2022.
29 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.